{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:53:50Z","timestamp":1790927630954,"version":"4.1.0"},"reference-count":30,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172339"],"award-info":[{"award-number":["82172339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018532","name":"Major Scientific and Technological Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["2021CXGC010603"],"award-info":[{"award-number":["2021CXGC010603"]}],"id":[{"id":"10.13039\/501100018532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tstp20221156"],"award-info":[{"award-number":["tstp20221156"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Stomach adenocarcinoma is among the most prevalent malignant gastrointestinal tumors worldwide. Ferroptosis, a relatively new form of programmed cell death, has garnered significant attention for its role in cancer molecular mechanisms and therapeutic strategies. Therefore, it is particularly important to explore the mechanism of key molecules in ferroptosis in stomach adenocarcinoma. In our study, CUGBP Elav-like family member 2 (CELF2) was identified as being lowly expressed in stomach adenocarcinoma tumor tissues at both the mRNA and protein levels. Next, CELF2 effectively inhibited the growth and migration of stomach adenocarcinoma cells both in vitro and in vivo. RNA sequencing (RNA-seq) analysis of AGSCELF2 and AGSNC cells showed that the functions of differentially expressed genes were enriched in the glutathione metabolism and ferroptosis pathways. CELF2 increased the levels of key ferroptosis markers, including reactive oxygen species, malondialdehyde, Fe2+, and 4-hydroxynonenal, while reducing glutathione levels. Furthermore, CELF2 enhanced the susceptibility of stomach adenocarcinoma tumor cells to ferroptosis. Interestingly, the expression levels of CELF2 and solute carrier family 7 member 11 (SLC7A11) were negatively correlated in RNA-seq data and The Cancer Genome Atlas database. RNA immunoprecipitation and RNA pull-down assays confirmed the interaction between CELF2 and SLC7A11. Overexpression (OE) of SLC7A11 reversed the effects of CELF2 on stomach adenocarcinoma growth and ferroptosis levels. Moreover, the ferroptosis inhibitor ferrostatin-1 effectively rescued the inhibitory effect of CELF2 OE on the proliferation of tumor cells. CELF2 is a tumor suppressor that promotes the level and susceptibility of ferroptosis in stomach adenocarcinoma cells by targeting SLC7A11.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications:<\/jats:title>\n                    <jats:p>This study offers valuable molecular insights for the development of ferroptosis-targeted therapies for stomach adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1541-7786.mcr-25-1017","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:39:16Z","timestamp":1781707156000},"page":"809-820","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CELF2 Is a Tumor Suppressor That Modulates SLC7A11 and Promotes Ferroptosis in Stomach Adenocarcinoma"],"prefix":"10.1158","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2633-1986","authenticated-orcid":false,"given":"Shoucai","family":"Zhang","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4869-1137","authenticated-orcid":false,"given":"Shichao","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4351-0391","authenticated-orcid":false,"given":"Zeyu","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3901-1652","authenticated-orcid":false,"given":"Yingjie","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4059-9967","authenticated-orcid":false,"given":"Maopeng","family":"Yin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2567-8844","authenticated-orcid":false,"given":"Xueyan","family":"Geng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7112-0921","authenticated-orcid":false,"given":"Helgi B.","family":"Schioth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/048a87296","id-type":"ROR","asserted-by":"publisher"}],"name":"Uppsala University 3 Department of Surgical Sciences, Functional Pharmacology and Neuroscience, , Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-1798","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"publisher"}],"name":"Qilu Hospital of Shandong University 1 Department of Clinical Laboratory, , Jinan, P.R. China."},{"name":"2Shandong Engineering Research Center of Biomarker and Artificial Intelligence Application, Jinan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2026100203093438200_bib1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026100203093438200_bib2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"2026100203093438200_bib3","doi-asserted-by":"publisher","first-page":"860344","DOI":"10.3389\/fcell.2022.860344","article-title":"Ferroptosis and its role in gastric cancer","volume":"10","author":"Gu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"2026100203093438200_bib4","doi-asserted-by":"publisher","first-page":"e16951","DOI":"10.7717\/peerj.16951","article-title":"Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics","volume":"12","author":"He","year":"2024","journal-title":"PeerJ"},{"key":"2026100203093438200_bib5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/nar\/gkh275","article-title":"ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo","volume":"32","author":"Singh","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2026100203093438200_bib6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.biochi.2005.10.011","article-title":"Mammalian CELF\/Bruno-like RNA-binding proteins: molecular characteristics and biological functions","volume":"88","author":"Barreau","year":"2006","journal-title":"Biochimie"},{"key":"2026100203093438200_bib7","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.3390\/cancers15205038","article-title":"CELF2 sustains a proliferating\/OLIG2+ glioblastoma cell phenotype via the epigenetic repression of SOX3","volume":"15","author":"Turchi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026100203093438200_bib8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12957-023-02993-z","article-title":"Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA","volume":"21","author":"Tuo","year":"2023","journal-title":"World J Surg Oncol"},{"key":"2026100203093438200_bib9","doi-asserted-by":"publisher","first-page":"125414","DOI":"10.1016\/j.jhazmat.2021.125414","article-title":"Triclosan regulates alternative splicing events of nerve-related genes through RNA-binding protein CELF2 to induce zebrafish neurotoxicity","volume":"413","author":"Wang","year":"2021","journal-title":"J Hazard Mater"},{"key":"2026100203093438200_bib10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3892\/etm.2021.10330","article-title":"RNA-binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1","volume":"22","author":"Zhou","year":"2021","journal-title":"Exp Ther Med"},{"key":"2026100203093438200_bib11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/ijd.17295","article-title":"Loss of CELF2 promotes skin tumorigenesis and increases drug resistance","volume":"64","author":"Sah","year":"2025","journal-title":"Int J Dermatol"},{"key":"2026100203093438200_bib12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"2026100203093438200_bib13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026100203093438200_bib14","doi-asserted-by":"publisher","first-page":"102541","DOI":"10.1016\/j.redox.2022.102541","article-title":"Inhibition of ferroptosis promotes retina ganglion cell survival in experimental optic neuropathies","volume":"58","author":"Guo","year":"2022","journal-title":"Redox Biol"},{"key":"2026100203093438200_bib15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2026100203093438200_bib16","doi-asserted-by":"publisher","first-page":"102564","DOI":"10.1016\/j.redox.2022.102564","article-title":"Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer","volume":"59","author":"Xu","year":"2023","journal-title":"Redox Biol"},{"key":"2026100203093438200_bib17","doi-asserted-by":"publisher","first-page":"6532253","DOI":"10.1155\/2022\/6532253","article-title":"LTBP2 knockdown promotes ferroptosis in gastric cancer cells through p62-keap1-nrf2 pathway","volume":"2022","author":"Wang","year":"2022","journal-title":"Biomed Res Int"},{"key":"2026100203093438200_bib18","doi-asserted-by":"publisher","first-page":"858462","DOI":"10.3389\/fonc.2022.858462","article-title":"The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer","volume":"12","author":"Jyotsana","year":"2022","journal-title":"Front Oncol"},{"key":"2026100203093438200_bib19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/ijms25021314","article-title":"Mitochondrial glutathione in cellular redox homeostasis and disease manifestation","volume":"25","author":"Chen","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026100203093438200_bib20","doi-asserted-by":"publisher","first-page":"154646","DOI":"10.1016\/j.prp.2023.154646","article-title":"SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K\/AKT pathway","volume":"248","author":"Jiang","year":"2023","journal-title":"Pathol Res Pract"},{"key":"2026100203093438200_bib21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41419-022-05173-1","article-title":"LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026100203093438200_bib22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/iub.2525","article-title":"CPEB1 enhances erastin-induced ferroptosis in gastric cancer cells by suppressing twist1 expression","volume":"73","author":"Wang","year":"2021","journal-title":"IUBMB Life"},{"key":"2026100203093438200_bib23","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol"},{"key":"2026100203093438200_bib24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41419-022-04579-1","article-title":"Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026100203093438200_bib25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","article-title":"Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer","volume":"40","author":"Yang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2026100203093438200_bib26","doi-asserted-by":"publisher","first-page":"e152067","DOI":"10.1172\/JCI152067","article-title":"RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11","volume":"131","author":"Zhang","year":"2021","journal-title":"J Clin Invest"},{"key":"2026100203093438200_bib27","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int J Biol Sci"},{"key":"2026100203093438200_bib28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/SHK.0000000000002339","article-title":"miR-208a-3p regulated by circUQCRC2 suppresses ischemia\/reperfusion-induced acute kidney injury by inhibiting CELF2-mediated tubular epithelial cell apoptosis, inflammation and ferroptosis","volume":"61","author":"Huang","year":"2024","journal-title":"Shock"},{"key":"2026100203093438200_bib29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ijmm.2023.5291","article-title":"Role of CELF2 in ferroptosis: potential targets for cancer therapy (review)","volume":"52","author":"Li","year":"2023","journal-title":"Int J Mol Med"},{"key":"2026100203093438200_bib30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","article-title":"ATF3 promotes erastin-induced ferroptosis by suppressing system Xc","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Death Differ"}],"container-title":["Molecular Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/doi\/10.1158\/1541-7786.MCR-25-1017\/3804449\/mcr-25-1017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/doi\/10.1158\/1541-7786.MCR-25-1017\/3813455\/mcr-25-1017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/24\/10\/809\/3832234\/mcr-25-1017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/24\/10\/809\/3832234\/mcr-25-1017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:09:45Z","timestamp":1790924985000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/mcr\/article\/24\/10\/809\/788441\/CELF2-Is-a-Tumor-Suppressor-That-Modulates-SLC7A11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,10,2]]}},"URL":"https:\/\/doi.org\/10.1158\/1541-7786.mcr-25-1017","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1541-7786.c.8750707","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1541-7786.34055503","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055491","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055506","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055485","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055509","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055494","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055488","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055500","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.34055497","asserted-by":"object"}]},"ISSN":["1541-7786","1557-3125"],"issn-type":[{"value":"1541-7786","type":"print"},{"value":"1557-3125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}